Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Revenue Breakdown and Options Chain

Gain deeper insights into company revenues with a detailed analysis of revenue sources.
Explore the updated Options feature, providing in-depth data, and a 3D viewing option.

Last Close
Mar 01 04:00PM ET
178.91
Dollar change
+2.86
Percentage change
1.62
%
IndexS&P 500 P/E65.77 EPS (ttm)2.72 Insider Own0.15% Shs Outstand1.77B Perf Week0.46%
Market Cap316.04B Forward P/E14.68 EPS next Y12.19 Insider Trans-10.36% Shs Float1.76B Perf Month8.83%
Income4.82B PEG20.07 EPS next Q2.37 Inst Own71.99% Short Float0.84% Perf Quarter29.18%
Sales54.32B P/S5.82 EPS this Y0.57% Inst Trans0.10% Short Ratio2.71 Perf Half Y20.62%
Book/sh5.87 P/B30.50 EPS next Y9.07% ROA3.52% Short Interest14.75M Perf Year15.23%
Cash/sh7.26 P/C24.66 EPS next 5Y3.28% ROE34.90% 52W Range130.96 - 179.89 Perf YTD15.45%
Dividend Est.6.23 (3.48%) P/FCF14.35 EPS past 5Y-5.77% ROI7.61% 52W High-0.54% Beta0.56
Dividend TTM5.99 (3.35%) Quick Ratio0.76 Sales past 5Y11.76% Gross Margin70.40% 52W Low36.61% ATR (14)2.87
Dividend Ex-DateApr 12, 2024 Current Ratio0.87 EPS Y/Y TTM-59.03% Oper. Margin37.04% RSI (14)67.44 Volatility1.52% 1.86%
Employees50000 Debt/Eq5.80 Sales Y/Y TTM-6.44% Profit Margin8.87% Recom1.89 Target Price180.38
Option/ShortYes / Yes LT Debt/Eq5.11 EPS Q/Q-67.09% Payout220.33% Rel Volume0.74 Prev Close176.05
Sales Surprise1.97% EPS Surprise-0.11% Sales Q/Q-5.42% EarningsFeb 02 BMO Avg Volume5.44M Price178.91
SMA202.32% SMA507.61% SMA20019.59% Trades Volume4,028,546 Change1.62%
Date Action Analyst Rating Change Price Target Change
Jan-29-24Upgrade William Blair Mkt Perform → Outperform
Dec-18-23Downgrade HSBC Securities Buy → Hold
Dec-11-23Upgrade Goldman Neutral → Buy
Nov-09-23Initiated Deutsche Bank Hold $150
Oct-30-23Upgrade Barclays Equal Weight → Overweight $160 → $170
Oct-20-23Resumed UBS Neutral $157 → $150
Sep-29-23Initiated Raymond James Outperform $177
Jul-25-23Initiated William Blair Mkt Perform
Jul-14-23Initiated HSBC Securities Buy $167
Apr-05-23Downgrade Argus Buy → Hold
Mar-01-24 11:35PM
05:45PM
10:12AM
09:00AM
Feb-29-24 09:45AM
08:00AM Loading…
08:00AM
Feb-28-24 02:02PM
11:05AM
10:17AM
09:36AM
05:27AM
12:05AM
Feb-27-24 09:23AM
08:00AM
08:00AM
07:45AM Loading…
07:45AM
07:45AM
05:45AM
Feb-26-24 07:45PM
07:20AM
Feb-24-24 03:00PM
07:04AM
Feb-22-24 04:48PM
09:11AM
08:05AM
05:15AM
Feb-21-24 06:41PM
06:02PM
05:39PM
11:45AM
10:43AM Loading…
10:43AM
09:12AM
08:00AM
12:02AM
Feb-20-24 12:48PM
11:21AM
10:18AM
09:17AM
09:05AM
09:00AM
07:00AM
04:52AM
Feb-19-24 10:15AM
09:00AM
08:30AM
Feb-17-24 01:29PM
Feb-15-24 12:03PM
08:45AM
Feb-14-24 02:02PM
Feb-13-24 06:02AM
Feb-12-24 12:18PM
07:37AM
07:30AM
Feb-11-24 08:25AM
Feb-10-24 08:30AM
Feb-08-24 08:00AM
Feb-07-24 10:13AM
Feb-06-24 01:53PM
12:00PM
09:00AM
09:00AM
06:01AM
Feb-05-24 07:37PM
06:55PM
04:00PM
02:58PM
11:45AM
08:54AM
07:00AM
Feb-04-24 06:24PM
05:50AM
Feb-03-24 08:12AM
03:56AM
Feb-02-24 03:47PM
03:45PM
02:41PM
01:12PM
01:04PM
12:12PM
12:08PM
11:27AM
11:08AM
10:00AM
08:45AM
08:16AM
08:12AM
07:43AM
07:39AM
07:36AM
07:36AM
Jan-31-24 11:00AM
Jan-30-24 03:57PM
01:50PM
09:15AM
07:59AM
Jan-29-24 05:45PM
04:09PM
04:00PM
Jan-28-24 11:42AM
Jan-26-24 10:00AM
AbbVie, Inc. is a research-based biopharmaceutical company, which engages in the development and sale of pharmaceutical products. It focuses on treating conditions such as chronic autoimmune diseases in rheumatology, gastroenterology, and dermatology, oncology, including blood cancers, virology, hepatitis C virus (HCV) and human immunodeficiency virus (HIV), neurological disorders, such as Parkinson's, metabolic, comprising thyroid disease and complications associated with cystic fibrosis, pain associated with endometriosis, and other serious health conditions. The company was founded on October 19, 2011 and is headquartered in North Chicago, IL.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Michael Robert A.PRES & CHIEF OPERATING OFFICERFeb 29Option Exercise58.3021,5601,257,012167,524Mar 01 05:50 PM
Michael Robert A.PRES & CHIEF OPERATING OFFICERFeb 29Sale176.4568,87912,153,95798,645Mar 01 05:50 PM
Siatis Perry CEVP, GC AND SECRETARYFeb 29Sale177.399,8911,754,55510,397Mar 01 05:50 PM
Buckbee Kevin KSVP, CONTROLLERFeb 29Sale176.655,144908,6886,983Mar 01 05:50 PM
GONZALEZ RICHARD ACHAIRMAN OF THE BOARD AND CEOFeb 28Sale177.27138,61624,572,458519,099Mar 01 05:50 PM
Siatis Perry CEVP, GC AND SECRETARYFeb 23Option Exercise137.3613,7531,889,11541,926Feb 27 05:10 PM
Reents Scott TEVP, CHIEF FINANCIAL OFFICERFeb 23Option Exercise61.3614,140867,63041,205Mar 01 05:50 PM
Reents Scott TEVP, CHIEF FINANCIAL OFFICERFeb 23Sale177.4414,1402,509,00227,065Mar 01 05:50 PM
Siatis Perry CEVP, GC AND SECRETARYFeb 23Sale177.5113,7532,441,29528,173Feb 27 05:10 PM
SALEKI-GERHARDT AZITAEVP, CHIEF OPERATIONS OFFICERFeb 21Option Exercise58.8852,8703,112,986296,814Feb 23 05:00 PM
SALEKI-GERHARDT AZITAEVP, CHIEF OPERATIONS OFFICERFeb 21Sale173.7152,8709,184,048243,944Feb 23 05:00 PM
Donoghoe NicholasEVP, CHIEF BUS/STRAT OFFICERDec 26Sale154.722,912450,54555,903Dec 28 05:00 PM
GONZALEZ RICHARD ACHAIRMAN OF THE BOARD AND CEOAug 01Sale148.5860,0008,914,800565,294Aug 02 05:07 PM
GONZALEZ RICHARD ACHAIRMAN OF THE BOARD AND CEOJul 31Sale149.1518,5002,759,275625,294Aug 02 05:07 PM
Sorg Elaine K.SVP, US COMMERCIAL OPERATIONSApr 25Option Exercise144.546,130886,03041,460Apr 27 05:00 PM
Sorg Elaine K.SVP, US COMMERCIAL OPERATIONSApr 25Sale165.006,1301,011,45035,330Apr 27 05:00 PM
Sorg Elaine K.SVP, US COMMERCIAL OPERATIONSApr 17Sale161.677,4991,212,33835,330Apr 19 05:00 PM
Sorg Elaine K.SVP, US COMMERCIAL OPERATIONSApr 03Option Exercise93.5015,0021,402,68757,831Apr 05 05:00 PM
Siatis Perry CEVP, GC AND SECRETARYApr 03Option Exercise105.923,520372,83813,897Apr 05 05:00 PM
Sorg Elaine K.SVP, US COMMERCIAL OPERATIONSApr 03Sale160.0315,0022,400,77042,829Apr 05 05:00 PM
Siatis Perry CEVP, GC AND SECRETARYApr 03Sale160.003,520563,20010,377Apr 05 05:00 PM
Stewart Jeffrey RyanEVP, CHIEF COMMERCIAL OFFICERMar 13Option Exercise54.8621,8101,196,497114,066Mar 15 05:00 PM
Stewart Jeffrey RyanEVP, CHIEF COMMERCIAL OFFICERMar 13Sale152.2853,1258,089,99860,941Mar 15 05:00 PM